Flagship Ventures creates and finances companies in therapeutics, medical technologies and sustainability.


06.18.2013	Mascoma Announces FDA Favorable Review of its Next Generation Bioengineered Yeast, TransFerm® Yield+
06.12.2013	Tangent Medical Showcases the NovaCath(TM) Integrated IV Catheter System at National Event Committed to Healthcare Innovation
06.12.2013	BG Medicine Welcomes Inclusion of Galectin-3 as Biomarker of Myocardial Fibrosis in 2013 ACCF/AHA Guideline for Management of Heart Failure
06.11.2013	Agios Pharmaceuticals files for IPO of up to $86 million
06.10.2013	Concert Pharmaceuticals Initiates Phase 1 Clinical Trial of CTP-354, a Potential Treatment for Spasticity and Pain
06.10.2013	Lallemand Biofuels & Distilled Spirits and Mascoma Announce Introduction of Next Generation Bioengineered Yeast